Skip to main content
Signal8

PetVivo Holdings, Inc. (PETV)

PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

PetVivo Holdings, Inc. logo

PetVivo Holdings, Inc.

OTC:PETVHealthcare
-32.04%$0.3500
CLOSED
Mkt Cap$13.28M
EV-
Float33.56M
O/S37.95M
VOL96K sh
$ Vol$38K
RVOL5.65×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
PetVivo Holdings, Inc. logoOTC:PETVClosed$0.3500-32.04%

PetVivo Holdings, Inc. (PETV) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 4 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
7 warrant series recorded as outstanding
Most recent offering
PIPE, closed Jun 24, 2025
Source: 10-Q filed Aug 14, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro